Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design
Statistical experimental design was applied to evaluate the influence of some process and formulation variables and possible interactions among such variables, on didanosine release from directly-compressed matrix tablets based on blends of two insoluble polymers, Eudragit RS-PM and Ethocel 100, wit...
Gespeichert in:
Veröffentlicht in: | International journal of pharmaceutics 2002-04, Vol.237 (1), p.107-118 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 118 |
---|---|
container_issue | 1 |
container_start_page | 107 |
container_title | International journal of pharmaceutics |
container_volume | 237 |
creator | Sánchez-Lafuente, Carla Furlanetto, Sandra Fernández-Arévalo, Mercedes Alvarez-Fuentes, Josefa Rabasco, Antonio M. Faucci, M.Teresa Pinzauti, Sergio Mura, Paola |
description | Statistical experimental design was applied to evaluate the influence of some process and formulation variables and possible interactions among such variables, on didanosine release from directly-compressed matrix tablets based on blends of two insoluble polymers, Eudragit RS-PM and Ethocel 100, with the final goal of drug release behavior optimization. The considered responses were the percent of drug released at three determined times, the dissolution efficiency at 6 h and the time to dissolve 10% of drug. Four independent variables were considered: tablet compression force, ratio between the polymers and their particle size, and drug content. The preliminary screening step, carried out by means of a 12-run asymmetric screening matrix according to a D-optimal design strategy, allowed evaluation of the effects of different levels of each variable. The drug content and the polymers ratio had the most important effect on drug release, which, moreover, was favored by greater polymers particle size; on the contrary the compression force did not have a significant effect. The Doehlert design was then applied for a response-surface study, in order to study in depth the effects of the most important variables. The desirability function was used to simultaneously optimize the five considered responses, each having a different target. This procedure allowed selection, in the studied experimental domain, of the best formulation conditions to optimize drug release rate. The experimental values obtained from the optimized formulation highly agreed with the predicted values. The results demonstrated the reliability of the model in the preparation of extended-release matrix tablets with predictable drug release profiles. |
doi_str_mv | 10.1016/S0378-5173(02)00028-5 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71607090</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517302000285</els_id><sourcerecordid>71607090</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-4e77fae8086869e55e6e9bac111658d633d9c0f545febfa0e17db01a348b7bb03</originalsourceid><addsrcrecordid>eNqFkMtuFDEQRS0EIpPAJ4B6A4JFgz0eP5oNQgkvKRILYG257XJk1G0PLncIfD3uzIgsWVnXOnWrdAh5wugrRpl8_ZVypXvBFH9Bty8ppduW7pEN04r3fKfkfbL5h5yQU8QfDZJbxh-SE8YGITQdNuTXRfQ2ZYwJOripkDz4vsAEFqGbbS3xpqt2nKDimy7va5zjH1tjTl0OXchlXqZDvLYlrhx2Syu76rC2f6zR2akV76HEGVJtwQPGq_SIPAh2Qnh8fM_I9w_vv51_6i-_fPx8_u6yd3xgtd-BUsGCplpqOYAQIGEYrWOMSaG95NwPjgaxEwHGYCkw5UfKLN_pUY0j5Wfk-aF3X_LPBbCaOaKDabIJ8oJGMUkVHVZQHEBXMmKBYPbtZFt-G0bNatzcGjerTkO35ta4EW3u6XHBMs7g76aOihvw7AhYbDJCsclFvOO4ZJzqtejtgYOm4zpCMegiJAc-FnDV-Bz_c8pfqt6gzA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71607090</pqid></control><display><type>article</type><title>Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Sánchez-Lafuente, Carla ; Furlanetto, Sandra ; Fernández-Arévalo, Mercedes ; Alvarez-Fuentes, Josefa ; Rabasco, Antonio M. ; Faucci, M.Teresa ; Pinzauti, Sergio ; Mura, Paola</creator><creatorcontrib>Sánchez-Lafuente, Carla ; Furlanetto, Sandra ; Fernández-Arévalo, Mercedes ; Alvarez-Fuentes, Josefa ; Rabasco, Antonio M. ; Faucci, M.Teresa ; Pinzauti, Sergio ; Mura, Paola</creatorcontrib><description>Statistical experimental design was applied to evaluate the influence of some process and formulation variables and possible interactions among such variables, on didanosine release from directly-compressed matrix tablets based on blends of two insoluble polymers, Eudragit RS-PM and Ethocel 100, with the final goal of drug release behavior optimization. The considered responses were the percent of drug released at three determined times, the dissolution efficiency at 6 h and the time to dissolve 10% of drug. Four independent variables were considered: tablet compression force, ratio between the polymers and their particle size, and drug content. The preliminary screening step, carried out by means of a 12-run asymmetric screening matrix according to a D-optimal design strategy, allowed evaluation of the effects of different levels of each variable. The drug content and the polymers ratio had the most important effect on drug release, which, moreover, was favored by greater polymers particle size; on the contrary the compression force did not have a significant effect. The Doehlert design was then applied for a response-surface study, in order to study in depth the effects of the most important variables. The desirability function was used to simultaneously optimize the five considered responses, each having a different target. This procedure allowed selection, in the studied experimental domain, of the best formulation conditions to optimize drug release rate. The experimental values obtained from the optimized formulation highly agreed with the predicted values. The results demonstrated the reliability of the model in the preparation of extended-release matrix tablets with predictable drug release profiles.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/S0378-5173(02)00028-5</identifier><identifier>PMID: 11955809</identifier><identifier>CODEN: IJPHDE</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Anti-HIV Agents - chemistry ; Anti-HIV Agents - pharmacokinetics ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Biological and medical sciences ; Chemistry, Pharmaceutical ; Delayed-Action Preparations - chemistry ; Delayed-Action Preparations - pharmacokinetics ; Didanosine ; Didanosine - chemistry ; Didanosine - pharmacokinetics ; Extended-release inert matrix tablets ; General pharmacology ; Medical sciences ; Models, Statistical ; Multiple response optimization ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Response surface methodology ; Statistical experimental design ; Tablets - chemistry ; Tablets - pharmacokinetics</subject><ispartof>International journal of pharmaceutics, 2002-04, Vol.237 (1), p.107-118</ispartof><rights>2002 Elsevier Science B.V.</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-4e77fae8086869e55e6e9bac111658d633d9c0f545febfa0e17db01a348b7bb03</citedby><cites>FETCH-LOGICAL-c391t-4e77fae8086869e55e6e9bac111658d633d9c0f545febfa0e17db01a348b7bb03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0378-5173(02)00028-5$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13613085$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11955809$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sánchez-Lafuente, Carla</creatorcontrib><creatorcontrib>Furlanetto, Sandra</creatorcontrib><creatorcontrib>Fernández-Arévalo, Mercedes</creatorcontrib><creatorcontrib>Alvarez-Fuentes, Josefa</creatorcontrib><creatorcontrib>Rabasco, Antonio M.</creatorcontrib><creatorcontrib>Faucci, M.Teresa</creatorcontrib><creatorcontrib>Pinzauti, Sergio</creatorcontrib><creatorcontrib>Mura, Paola</creatorcontrib><title>Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>Statistical experimental design was applied to evaluate the influence of some process and formulation variables and possible interactions among such variables, on didanosine release from directly-compressed matrix tablets based on blends of two insoluble polymers, Eudragit RS-PM and Ethocel 100, with the final goal of drug release behavior optimization. The considered responses were the percent of drug released at three determined times, the dissolution efficiency at 6 h and the time to dissolve 10% of drug. Four independent variables were considered: tablet compression force, ratio between the polymers and their particle size, and drug content. The preliminary screening step, carried out by means of a 12-run asymmetric screening matrix according to a D-optimal design strategy, allowed evaluation of the effects of different levels of each variable. The drug content and the polymers ratio had the most important effect on drug release, which, moreover, was favored by greater polymers particle size; on the contrary the compression force did not have a significant effect. The Doehlert design was then applied for a response-surface study, in order to study in depth the effects of the most important variables. The desirability function was used to simultaneously optimize the five considered responses, each having a different target. This procedure allowed selection, in the studied experimental domain, of the best formulation conditions to optimize drug release rate. The experimental values obtained from the optimized formulation highly agreed with the predicted values. The results demonstrated the reliability of the model in the preparation of extended-release matrix tablets with predictable drug release profiles.</description><subject>Anti-HIV Agents - chemistry</subject><subject>Anti-HIV Agents - pharmacokinetics</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Biological and medical sciences</subject><subject>Chemistry, Pharmaceutical</subject><subject>Delayed-Action Preparations - chemistry</subject><subject>Delayed-Action Preparations - pharmacokinetics</subject><subject>Didanosine</subject><subject>Didanosine - chemistry</subject><subject>Didanosine - pharmacokinetics</subject><subject>Extended-release inert matrix tablets</subject><subject>General pharmacology</subject><subject>Medical sciences</subject><subject>Models, Statistical</subject><subject>Multiple response optimization</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Response surface methodology</subject><subject>Statistical experimental design</subject><subject>Tablets - chemistry</subject><subject>Tablets - pharmacokinetics</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtuFDEQRS0EIpPAJ4B6A4JFgz0eP5oNQgkvKRILYG257XJk1G0PLncIfD3uzIgsWVnXOnWrdAh5wugrRpl8_ZVypXvBFH9Bty8ppduW7pEN04r3fKfkfbL5h5yQU8QfDZJbxh-SE8YGITQdNuTXRfQ2ZYwJOripkDz4vsAEFqGbbS3xpqt2nKDimy7va5zjH1tjTl0OXchlXqZDvLYlrhx2Syu76rC2f6zR2akV76HEGVJtwQPGq_SIPAh2Qnh8fM_I9w_vv51_6i-_fPx8_u6yd3xgtd-BUsGCplpqOYAQIGEYrWOMSaG95NwPjgaxEwHGYCkw5UfKLN_pUY0j5Wfk-aF3X_LPBbCaOaKDabIJ8oJGMUkVHVZQHEBXMmKBYPbtZFt-G0bNatzcGjerTkO35ta4EW3u6XHBMs7g76aOihvw7AhYbDJCsclFvOO4ZJzqtejtgYOm4zpCMegiJAc-FnDV-Bz_c8pfqt6gzA</recordid><startdate>20020426</startdate><enddate>20020426</enddate><creator>Sánchez-Lafuente, Carla</creator><creator>Furlanetto, Sandra</creator><creator>Fernández-Arévalo, Mercedes</creator><creator>Alvarez-Fuentes, Josefa</creator><creator>Rabasco, Antonio M.</creator><creator>Faucci, M.Teresa</creator><creator>Pinzauti, Sergio</creator><creator>Mura, Paola</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020426</creationdate><title>Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design</title><author>Sánchez-Lafuente, Carla ; Furlanetto, Sandra ; Fernández-Arévalo, Mercedes ; Alvarez-Fuentes, Josefa ; Rabasco, Antonio M. ; Faucci, M.Teresa ; Pinzauti, Sergio ; Mura, Paola</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-4e77fae8086869e55e6e9bac111658d633d9c0f545febfa0e17db01a348b7bb03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Anti-HIV Agents - chemistry</topic><topic>Anti-HIV Agents - pharmacokinetics</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Biological and medical sciences</topic><topic>Chemistry, Pharmaceutical</topic><topic>Delayed-Action Preparations - chemistry</topic><topic>Delayed-Action Preparations - pharmacokinetics</topic><topic>Didanosine</topic><topic>Didanosine - chemistry</topic><topic>Didanosine - pharmacokinetics</topic><topic>Extended-release inert matrix tablets</topic><topic>General pharmacology</topic><topic>Medical sciences</topic><topic>Models, Statistical</topic><topic>Multiple response optimization</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Response surface methodology</topic><topic>Statistical experimental design</topic><topic>Tablets - chemistry</topic><topic>Tablets - pharmacokinetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sánchez-Lafuente, Carla</creatorcontrib><creatorcontrib>Furlanetto, Sandra</creatorcontrib><creatorcontrib>Fernández-Arévalo, Mercedes</creatorcontrib><creatorcontrib>Alvarez-Fuentes, Josefa</creatorcontrib><creatorcontrib>Rabasco, Antonio M.</creatorcontrib><creatorcontrib>Faucci, M.Teresa</creatorcontrib><creatorcontrib>Pinzauti, Sergio</creatorcontrib><creatorcontrib>Mura, Paola</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sánchez-Lafuente, Carla</au><au>Furlanetto, Sandra</au><au>Fernández-Arévalo, Mercedes</au><au>Alvarez-Fuentes, Josefa</au><au>Rabasco, Antonio M.</au><au>Faucci, M.Teresa</au><au>Pinzauti, Sergio</au><au>Mura, Paola</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2002-04-26</date><risdate>2002</risdate><volume>237</volume><issue>1</issue><spage>107</spage><epage>118</epage><pages>107-118</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><coden>IJPHDE</coden><abstract>Statistical experimental design was applied to evaluate the influence of some process and formulation variables and possible interactions among such variables, on didanosine release from directly-compressed matrix tablets based on blends of two insoluble polymers, Eudragit RS-PM and Ethocel 100, with the final goal of drug release behavior optimization. The considered responses were the percent of drug released at three determined times, the dissolution efficiency at 6 h and the time to dissolve 10% of drug. Four independent variables were considered: tablet compression force, ratio between the polymers and their particle size, and drug content. The preliminary screening step, carried out by means of a 12-run asymmetric screening matrix according to a D-optimal design strategy, allowed evaluation of the effects of different levels of each variable. The drug content and the polymers ratio had the most important effect on drug release, which, moreover, was favored by greater polymers particle size; on the contrary the compression force did not have a significant effect. The Doehlert design was then applied for a response-surface study, in order to study in depth the effects of the most important variables. The desirability function was used to simultaneously optimize the five considered responses, each having a different target. This procedure allowed selection, in the studied experimental domain, of the best formulation conditions to optimize drug release rate. The experimental values obtained from the optimized formulation highly agreed with the predicted values. The results demonstrated the reliability of the model in the preparation of extended-release matrix tablets with predictable drug release profiles.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>11955809</pmid><doi>10.1016/S0378-5173(02)00028-5</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0378-5173 |
ispartof | International journal of pharmaceutics, 2002-04, Vol.237 (1), p.107-118 |
issn | 0378-5173 1873-3476 |
language | eng |
recordid | cdi_proquest_miscellaneous_71607090 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Anti-HIV Agents - chemistry Anti-HIV Agents - pharmacokinetics Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Biological and medical sciences Chemistry, Pharmaceutical Delayed-Action Preparations - chemistry Delayed-Action Preparations - pharmacokinetics Didanosine Didanosine - chemistry Didanosine - pharmacokinetics Extended-release inert matrix tablets General pharmacology Medical sciences Models, Statistical Multiple response optimization Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Response surface methodology Statistical experimental design Tablets - chemistry Tablets - pharmacokinetics |
title | Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T20%3A02%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Didanosine%20extended-release%20matrix%20tablets:%20optimization%20of%20formulation%20variables%20using%20statistical%20experimental%20design&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=S%C3%A1nchez-Lafuente,%20Carla&rft.date=2002-04-26&rft.volume=237&rft.issue=1&rft.spage=107&rft.epage=118&rft.pages=107-118&rft.issn=0378-5173&rft.eissn=1873-3476&rft.coden=IJPHDE&rft_id=info:doi/10.1016/S0378-5173(02)00028-5&rft_dat=%3Cproquest_cross%3E71607090%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71607090&rft_id=info:pmid/11955809&rft_els_id=S0378517302000285&rfr_iscdi=true |